JPMorgan initiated coverage of Blueprint Medicines (BPMC) with an Overweight rating and $126 price target Blueprint is a biotech company ...
Live webcasts of the presentations will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...
An estimated 1 to 3 million people suffer from POTS. In addition to POTS, Knowles struggles with Sjögren’s syndrome and mast ...
Caroline Quinn, 25, from Boston, MA, faces unique challenges in love due to a rare immune disease and severe allergies. With ...
HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: Guggenheim ...
A woman with over 100 allergies has divided much of the internet after showing how she orders food at a restaurant. Jenna ...
Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs ...
Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...
Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...
Histamine plays an important role in healthy immune functioning and neurotransmitter signaling. However, when these naturally ...